X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/manufacturing/endos-par-pharma-issues-recall-blood-pressure-med-due-possible-contamination
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/par-pharmaceutical-issues-voluntary-nationwide-recall-one-lot-treprostinil-injection-due-potential
https://www.prnewswire.com/news-releases/par-pharmaceutical-issues-voluntary-nationwide-recall-of-one-lot-of-treprostinil-injection-due-to-potential-for-silicone-particulates-in-the-product-solution-302087106.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205976
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205770
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216843
https://www.fiercepharma.com/pharma/novartis-pays-245m-settle-exforge-generic-pay-delay-lawsuits
https://news.bloomberglaw.com/health-law-and-business/adderall-shortages-in-us-spread-to-two-more-drug-suppliers?context=search&index=11
https://www.reuters.com/legal/litigation/endo-loses-appeal-challenging-generic-version-best-seller-vasostrict-2022-08-18/?rpc=401&
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216198
Market Place
Share 
